Gate2Brain: Funding, Investors & Team (Sep 2026)
Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. Gate2Brain pursues its goals using a radically innovative peptide-based patented technology platform. G2B-002, Gate2Brain flagship product and proof of concept of the technology, offers a new therapeutic approach with improved biopharmaceutical properties and potent activity against rare paediatric cancers.
Gate2Brain has raised $10.8M across 2 funding rounds on record, the most recent an undisclosed round of $8.1M announced in Jun 2026.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Gate2Brain Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Gate2Brain Funding Rounds
Gate2Brain raised $2.7M in an undisclosed round announced in Dec 2022.
3.5 years later, an undisclosed round of $8.1M was announced in Jun 2026.
Gate2Brain Founders and Leadership Team
Contact details for the Gate2Brain team: 1 of 1 has an email address on file.
Start 14-day free trial →Gate2Brain Funding Compared to Other Biotechnology Startups
Gate2Brain's latest round of $8.1M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Gate2Brain in Biotechnology and Barcelona
Companies Similar to Gate2Brain
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic…
IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues…
Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs…
Modern medicine fails because it studies life in static environments. 60Nd revolutionizes the field with…
Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The…
Universal Diagnostics S.A. (UDX) is a company in Spain that specializes in in-vitro diagnostics. Their focus…
Phyture Biotech originated as a spin-off of the Faculty of Pharmacy at the University of Barcelona, founded…
Polimerbio offers sanitary product design and development based on biocompatible polymers, particularly…
Overture Life is a biotechnology company that specializes in developing automated technologies for assisted…
In order to cure diseases with unmet medical requirements, ARTHEx Biotech, a biotech business that was spun…
Highlight Therapeutics is a private, clinical-stage company dedicated to unlocking the full potential of…
Gate2Brain Funding FAQs
What does Gate2Brain do?
Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. Gate2Brain pursues its goals using a radically innovative peptide-based patented technology platform. G2B-002, Gate2Brain flagship product and proof of concept of the technology, offers a new therapeutic approach with improved biopharmaceutical properties and potent activity against rare paediatric cancers.
How much funding has Gate2Brain raised?
Gate2Brain has raised $10.8M across 2 rounds on record. The most recent is an undisclosed round of $8.1M announced in Jun 2026.
When did Gate2Brain last raise funding?
Gate2Brain's most recent funding round on record is an undisclosed round of $8.1M, announced in Jun 2026.
Who is the CEO of Gate2Brain?
Meritxell Teixido is listed as CEO at Gate2Brain.
Where is Gate2Brain headquartered?
Gate2Brain is based in Barcelona, Catalonia, Spain.
How many employees does Gate2Brain have?
Gate2Brain is in the 1-10 employee band.
How does Gate2Brain's funding compare to other Biotechnology startups?
Gate2Brain's latest round of $8.1M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Gate2Brain Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Gate2Brain is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.